Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Clinical Pharmacology
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Clinical Pharmacology
    Intravitreal Triamcinolone May Slow Progression of Diabetic Retinopathy - (DGNews)
    Exemestane Therapy Show Unfavourable Changes in Lipid Profile: Presented at SABCS - (DGDispatch)
    Bevacizumab Plus Docetaxel Improves Progression-Free Survival, but Not Overall Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
    Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
    FDA Approves Long-Acting Olanzapine Intramuscular Injection for Schizophrenia - (DGNews)

    News archive

     Recent webcasts/CME - Clinical Pharmacology
    • Practical Considerations in Management of Chronic Pain
    • Practical Considerations in Management of Chronic Pain
    • Hypertension in Blacks: Understanding the Scope of the Problem and Its Clinical Implications
    • Overview of Chronic Pain: Practical Definitions and Characteristics
    • The Current Problem of Buprenorphine Diversion & Misuse

      Webcasts/CME archive

       Recent cases - Clinical Pharmacology
        Gradual Progression of Interstitial Pneumonia Induced by Bepridil
        An Acutely Erythematous, Oedematous Penis And Antecubital Fossae Rash In A Patient Taking Etanercept: A Case Report
        Ulceration Of The Oral Mucosa Induced By Antidepressant Medication: A Case Report
        Dual Antiplatelet Therapy in Coronary Artery Disease: A Case-Based Approach
        Persistent Orocutaneous and Anal Fistulae Induced by Nicorandil: A Case Report

        Cases archive
          




        my personal edition > clinical pharmacology > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Report of H1N1 Cases in California Shows Hospitalisation Can Occur At All Ages

          CHICAGO -- November 3, 2009 -- In contrast with some common perceptions regarding influenza A(H1N1) infections, an examination of cases in California indicates that hospitalisation and death can occur at all ages, and about 30% of hospitalised cases have been severe enough to require treatment in an intensive care unit (ICU), according to a study in the November 4 issue of JAMA.

          Preliminary comparisons with seasonal influenza suggest that H1N1 disproportionately affects younger ages and causes generally mild disease.

          Janice K. Louie, MD, California Department of Public Health, Richmond, California, and colleagues examined the clinical and epidemiologic features of the first 1,088 hospitalised and fatal cases due to H1N1 reported in California between April 23 and August 11, 2009. On April 20, the California Department of Public Health and 61 local health departments initiated enhanced surveillance for hospitalised and fatal cases of H1N1.

          The researchers found that of the 1,088 H1N1 cases, 344 (32%) were children aged younger than 18 years, with infants having the highest rate of hospitalisation and persons aged 50 years or older having the highest rate of death once hospitalised. The median age of all cases was 27 years.

          Fever, cough, and shortness of breath were the most common symptoms. Underlying conditions previously associated with severe influenza were reported in 68% of cases. Other underlying medical illnesses recorded included obesity, hypertension, hyperlipidemia, and gastrointestinal disease. The median length of hospitalisation among all cases was 4 days.

          A total of 340 cases (31%) were admitted to ICUs, and of the 297 intensive care cases with available information, 65% required mechanical ventilation. Of the 884 cases with available information, 79% received antiviral treatment, including 496 patients (71%) with established risk factors for severe influenza. Of the 833 patients who had chest radiographs, 66% had infiltrates, suggestive of pneumonia or acute respiratory distress syndrome. Rapid antigen tests were falsely negative in 34% of cases evaluated.

          "Overall fatality was 11% (118/1,088) and was highest (18-20%) in persons aged 50 years or older," the researchers wrote. "Of the deaths, 8 (7%) were children younger than 18 years. Among fatal cases, the median time from onset of symptoms to death was 12 days." The most common causes of death were viral pneumonia and acute respiratory distress syndrome.

          "In the first 16 weeks of the current pandemic, H1N1 appears to be notably different from seasonal influenza, with fewer hospitalisations and fatalities occurring in elderly persons," they continued. "In contrast with the common perception that H1N1 causes only mild disease, hospitalisation and death occurred at all ages, and up to 30% of hospitalised cases were severely ill. Most hospitalised cases had identifiable established risk factors; obesity may be a newly identified risk factor for fatal H1N1 and merits further study."

          "Clinicians should maintain a high level of suspicion for H1N1 infection in patients presenting currently with influenza-like illness who are older than 50 years or have known risk factors for influenza complications, regardless of rapid test results," they concluded. "Hospitalised infected cases should be carefully monitored and treated promptly with antiviral agents."


          SOURCE: JAMA




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send